Can Ganoderma lucidum really cure cancer? Cancer is the most frightening and stubborn disease among all diseases. Can Ganoderma lucidum fight cancer? In recent years, clinical research on anti-cancer traditional Chinese medicine has attracted much attention from the medical community. , especially the research on the prevention and treatment of cancer with Ganoderma lucidum. Professor Lin Zhibin of Beijing Medical University told us that modern scientific research has confirmed that when combined with chemotherapy or radiotherapy, Ganoderma preparations have certain effects on gastric cancer, lung cancer, liver cancer, colon cancer, bladder cancer, kidney cancer, prostate cancer, ovarian cancer, and uterine cancer. The effect of adjuvant therapy, its efficacy characteristics are as follows: improve the tolerance of tumor patients to chemotherapy and radiotherapy; reduce the leukopenia, loss of appetite and other side effects caused by chemotherapy and radiotherapy; improve the cachexia of cancer patients, improve the quality of cancer patients Immune function and enhance the body’s anti-tumor immunity. Some cancer patients are in serious condition and cannot undergo surgical resection, chemotherapy or radiotherapy. After treatment with Ganoderma lucidum preparations, their condition improves and they can undergo surgery, chemotherapy or radiotherapy. Ganoderma lucidum and its active ingredients cannot directly kill tumor cells, and the tumor inhibition rate is also limited. According to reports, research on the anti-tumor effects of Ganoderma began in the 1980s, including in vivo and in vitro experiments. The former observes the inhibition of tumor growth after administration of Ganoderma lucidum preparations, or observes the survival time of tumor-bearing animals; the latter observes whether Ganoderma lucidum preparations can directly kill tumor cells on tumor cells cultured in vitro, which is the so-called cytotoxicity. effect. A large number of experimental results prove that Ganoderma lucidum and its active ingredients such as polysaccharides and triterpenoids have no cytotoxic effect, that is, they cannot directly kill tumor cells. However, in experimental animals inoculated with transplanted tumors, taking Ganoderma lucidum or its active ingredients orally or by injection can inhibit tumor growth and show a certain anti-tumor effect, but the tumor inhibition rate is not high, generally around 50% to 60%. Of course, medical experts have conducted systematic experimental research on the anti-tumor mechanism of Ganoderma lucidum and the main active ingredients it contains, and found that Ganoderma lucidum can enhance the phagocytic function of macrophages, promote the proliferation of T lymphocytes, and enhance the production of T killer cells. It has a toxic effect and promotes the production and gene expression of cytokines such as interleukin 1, 2, 6 and tumor necrosis factor. Recently, medical experiments have also confirmed that in vitro tests, Ganoderma lucidum polysaccharide cannot directly inhibit the proliferation of human leukemia cells (HL?0) and mouse S180 sarcoma cells, nor can it induce tumor cell apoptosis, but it can act on immune cells such as small cells. Mouse spleen lymphocytes or macrophages produce cytokines such as interleukin 2, interferon gamma, and tumor necrosis factor a, which indirectly inhibit tumor cell proliferation or induce tumor cell apoptosis. These experimental results all point out that Ganoderma lucidum and its active ingredients do not have direct cytotoxic effects, but they can indirectly inhibit tumor cell growth or induce tumor cell apoptosis by enhancing the body's anti-tumor immunity, and thus exert anti-tumor effects.

Hope to adopt